WordNet

any localized abnormal structural change in a bodily part
of or relating to or having vessels that conduct and circulate fluids; "vascular constriction"; "a vascular bundle"

PrepTutorEJDIC

傷害,傷 / (体の組織や機能の)障害
(血液・樹液などを運ぶ)管の,導管の,血管の

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 皮膚の良性病変の概要overview of benign lesions of the skin [show details]
…tissue spaces and hemosiderin deposition in the surrounding cells. These lesions are frequently clinically misdiagnosed as vascular lesions. Hemosiderotic – Hemosiderotic fibrous histiocytomas, composed of …
2. 新生児における血管病変vascular lesions in the newborn [show details]
… Vascular lesions, including vascular neoplasms and vascular malformations, are common in newborns . Although the majority of these lesions are benign and self-limited conditions, some may be part of complex …
3. 小児における身体的診察：背部、四肢、神経系、皮膚、およびリンパ節the pediatric physical examination back extremities nervous system skin and lymph nodes [show details]
… management of hemangiomas are discussed separately. Vascular lesions that neither proliferate nor involute and are caused by inborn errors of vascular morphogenesis are termed venous malformations . They …
4. 皮膚血管病変に対するレーザーおよび光線療法laser and light therapy for cutaneous vascular lesions [show details]
… ulcer. Telangiectasias are common, benign vascular lesions that are amenable to laser therapy. PDL and other vascular lasers can be effective for these lesions. …
5. 偶然見つかった腎病変の評価evaluation of the incidental renal lesion [show details]
… However, among the incidental renal lesions are benign tumors (eg, angiomyolipoma, oncocytoma), malignant tumors (eg, renal cell carcinoma), and vascular lesions (eg, arteriovenous fistula, renal artery …

English Journal

Feasibility of everolimus-eluting bioresorbable vascular scaffolds in patients with chronic total occlusion.

Wiebe J1, Liebetrau C2, Dörr O1, Most A1, Weipert K1, Rixe J1, Bauer T1, Möllmann H3, Elsässer A4, Hamm CW2, Nef HM5.
International journal of cardiology.Int J Cardiol.2015 Jan 20;179:90-4. doi: 10.1016/j.ijcard.2014.10.032. Epub 2014 Nov 7.
OBJECTIVE: This study evaluates the feasibility of percutaneous coronary intervention with bioresorbable vascular scaffolds (BVSs) in chronic total occlusion (CTO) lesions.BACKGROUND: Everolimus-eluting BVSs represent a new approach to treating coronary artery disease, but experience with CTO is lim
PMID 25464422

Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.

Lam MK1, Sen H1, van Houwelingen KG1, Löwik MM1, van der Heijden LC1, Kok MM1, de Man FH1, Linssen GC2, Tandjung K1, Doggen CJ3, von Birgelen C4.
American heart journal.Am Heart J.2015 Jan;169(1):69-77. doi: 10.1016/j.ahj.2014.10.011. Epub 2014 Oct 25.
BACKGROUND: Only limited data from large randomized clinical trials have been published on the long-term performance of second-generation drug-eluting stents in bifurcation lesions.METHODS: We investigated in patients in the randomized TWENTE trial the long-term safety and efficacy of treating bifur
PMID 25497250

A Prospective Evaluation of Using IVUS during Percutaneous Superficial Femoral Artery Interventions.

Hitchner E1, Zayed M2, Varu V2, Lee G3, Aalami O3, Zhou W4.
Annals of vascular surgery.Ann Vasc Surg.2015 Jan;29(1):28-33. doi: 10.1016/j.avsg.2014.07.026. Epub 2014 Sep 3.
BACKGROUND: The outcomes of endovascular interventions of the superficial femoral artery (SFA) are variable. Completion angiography is typically performed to confirm satisfactory outcomes after SFA angioplasty and/or stenting. However, two-dimensional angiography may not accurately reflect the exten
PMID 25194552